1:Clinical approach to suspected cancer
2:Concepts of multidisciplinary management
3:Tumours of the head and neck
4:Tumours of central nervous system
7:Cancers of gastrointestinal system
8:Cancers of genitourinary system
9:Cancers of female genital system
10:Cancer of the skin
11:Cancers of musculoskeletal system
12:Tumours of haemopoietic system
15:Oncological emergencies and acute oncology
16:Special situations in oncology
18:Clinical management of cancer - flowcharts
- Brings together essential, evidence-based clinical guidelines needed in the care and management of patients with cancer
- Distils and compiles all the literature on cancer into one easy-to-read volume
- Clear layout and succinct writing designed for the busy oncologist, for quick consultation in the clinic or on the ward
- A unique chapter of management flow charts facilitates fast and appropriate decision-making
This easy-to-read, practical guide distils and compiles all the disparate literature on cancer into one succinct volume. It includes the essential, evidence-based clinical guidelines needed for the safe and effective management of patients with cancer, and has a clear layout to allow for quick reference whilst on the ward.
All aspects of cancer and its management are covered, including prevention, screening, diagnosis, and treatment. The text begins by outlining the clinical approach to suspected cancer and the principles of multidisciplinary prevention and management. It then progresses through site-specific cancer management, including head and neck, CNS, thoracic, breast, gastrointestinal system, genitourinary system, female genital system, skin, musculoskeletal system, haemopoietic system, and endocrine. Later chapters cover oncological emergencies and acute oncology, and special situations such as cancer in younger and older people, and pregnancy and fertility.
The guide also offers information about coping with the lifestyle and social issues that may arise with a diagnosis of cancer, such as insurance, travel and support, and includes a chapter dedicated to palliative care for the cancer patient. A unique appendix of clinical management flowcharts assists fast, appropriate decision-making.
Edited by Thankamma Ajithkumar, Consultant Clinical Oncologist, Cambridge University Hospitals NHS Foundation Trust, UK, Ann Barrett, Professor Emeritus, University of East Anglia, Norfolk, UK, Helen Hatcher, Consultant in TYA and Medical Oncology, Cambridge University Hospitals NHS Foundation Trust, UK, and Sarah Jane Jefferies, Consultant Clinical Oncologist, Cambridge University Hospitals NHS Foundation Trust, UK
Dr Ajithkumar is a Consultant Clinical Oncologist at Addenbrooke's Hospital. He undertook a research fellowship in the Royal Marsden Hospital, London followed by speciality training in Clinical Oncology in the Eastern Deanery before becoming a Consultant Clinical Oncologist at the Bristol Haematology and Oncology Centre in 2006. In 2009 he moved to Norfolk and Norwich University Hospitals, subsequently moving to Cambridge in 2014. His research interest is to optimize the combination of radiotherapy with novel agents in paediatric brain tumours and hepato-pancreatico-biliary tumours to improve clinical outcomes. Dr Ajithkumar is Chair of the European Society of Paediatric Oncology (SIOPE) Brain Tumour Radiotherapy group. He is the principal investigator for the international Pediatric Normal Tissue Effects in the Clinic (PENTEC) Re-irradiation working group. He is also the radiotherapy lead for the CCLG CNS GCT subgroup and the radiotherapy research lead for the Cancer Research Network: Eastern.
Ann Barrett is Emeritus Professor of Oncology at the University of East Anglia, England, and was formerly deputy dean of the School of Medicine and lead clinician for oncology at the Norfolk and Norwich University Hospital NHS Trust. She was awarded an OBE in 2010 for services to medicine and is a fellow of the Royal College of Surgeons in Ireland.
Dr Hatcher is the Clinical and Regional lead for sarcoma and for teenagers and young adults with a variety of types of cancer. She specialises in sarcomas, paediatric tumours, late effects and survivorship and other rare cancers. She qualified in medicine at the University of Cambridge and has trained at the Royal Marsden Hospital in London. Her PhD and post-doctoral research investigated the genetics of tumour progression and secondary cancers. She has worked at the National Cancer Institute in the USA and the Haemonc unit at the Hospital of the University of Pennsylvania. Her current research interests include drug treatments in sarcomas, and psychological impacts of cancer. She is a member of the NCRN sarcoma clinical studies group, Regional Lead for sarcoma research and lead investigator in several multicentre and international trials.
Dr Sarah Jefferies is the Clinical Director for Cancer at Addenbrooke's Hospital. She qualified from University College London and trained in clinical oncology at the Royal Marsden Hospital. She undertook a PhD at the Institute of Cancer Research. Dr Jefferies specialist interests are the management of central nervous system (CNS) tumours and thyroid cancers. Dr Jefferies is lead investigator for a number of multicentre studies for CNS and thyroid tumours. She has an interest in teaching and leads both national and international courses in the management of CNS tumours. She is a member of the National Cancer Research Institute Brain Tumour group and is the chair of the Glioma Sub-group.